Suchergebnisse - "Kamerling, Ingrid M C"

PubPharm (50)

1

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination : a non-inferiority, randomized-controlled trial

enthalten in: NPJ vaccines | 2024

von Prins, M. | Roozen, G. | Pothast, C. | +21

2

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection : a randomised, double-blind, placebo-controlled study in the Netherlands

enthalten in: The Lancet. Infectious diseases | 2023

von van der Plas, J. | Kuiper, V. | Bagchus, W. | +22

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1102-1103. - PMID 37414067

3

Immunosuppression by hydroxychloroquine : mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von In 't Veld, A. | Grievink, H. | van der Plas, J. | +9

4

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19 : A phase 2a, open-label, single-dose escalation study

enthalten in: British journal of clinical pharmacology | 2023

von Prins, M. | van der Plas, J. | Vissers, M. | +13

5

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

6

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

7

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

8

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19 : A phase 2a, open‐label, single‐dose escalation study

enthalten in: British Journal of Clinical Pharmacology | 2023

von Prins, M. | Plas, J. | Vissers, M. | +13

9

First-in-human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324, a dual enkephalinase inhibitor for pain management

enthalten in: British journal of clinical pharmacology | 2022

von Moss, L. | Berends, C. | van Brummelen, E. | +7

10

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

enthalten in: British Journal of Clinical Pharmacology | 2022

von Moss, L. | Berends, C. | Brummelen, E. | +7

1
2
3
4
5
Nächster »
[5]